INTRODUCTION {#sec1}
============

Over the past decades, major industrial and academic research efforts have been devoted to engineering *Saccharomyces cerevisiae*, a key microbial cell factory (Liu, Redden and Alper [@bib33]; Nielsen *et al.*[@bib40]), for efficient conversion of lignocellulosic feedstocks into fuel ethanol, the largest-volume product of industrial biotechnology (reviewed by Alper and Stephanopoulos [@bib2]; Young, Lee and Alper [@bib74]; Moysés *et al.*[@bib38]; Jansen *et al.*[@bib19]). A large part of this effort was geared towards enabling *S. cerevisiae* strains to ferment [d]{.smallcaps}-xylose and [l]{.smallcaps}-arabinose, two pentoses that comprise a substantial fraction of the potentially fermentable sugars in lignocellulosic feedstocks (Lynd [@bib34]; Olsson and Hahn-Hägerdal [@bib42]; Moysés *et al.*[@bib38]; Jansen *et al.*[@bib19]). In lignocellulosic feedstocks, [d]{.smallcaps}-xylose is typically the most abundant sugar after glucose, often accounting for 10%--25% of the carbohydrate content (Lynd [@bib34]). Wild-type *S. cerevisiae* strains can grow, albeit slowly, on the [d]{.smallcaps}-xylose isomer [d]{.smallcaps}-xylulose, whose metabolism is linked to glycolysis via the combined action of xylulokinase (Xks1) and the enzymes of the non-oxidative pentose-phosphate pathway (PPP; Wang and Schneider [@bib71]; Hsiao *et al.*[@bib17]).

In naturally [d]{.smallcaps}-xylose-metabolizing, non-*Saccharomyces* yeasts such as *Scheffersomyces stipitis* (Toivola *et al.*[@bib62]), *Candida shehatae* (Toivola *et al.*[@bib62])*, Pachysolen tannophilus* (Smiley and Bolen [@bib58]; Toivola *et al.*[@bib62]), *Hansenula polymorpha* (Ryabova, Chmil and Sibirny [@bib52]) and *Kluyveromyces lactis* (Margaritis and Bajpai [@bib37]), [d]{.smallcaps}-xylose is first converted into [d]{.smallcaps}-xylulose by the combined action of pyridine-nucleotide-dependent xylose reductases (XR) and xylitol dehydrogenases (XDH). Metabolic engineering strategies for enabling anaerobic fermentation of [d]{.smallcaps}-xylose by *S. cerevisiae* based on expression of heterologous XR/XDH genes, which continue to be intensively investigated, are complicated by the different redox cofactor preferences of these two oxido-reductases (Kötter and Ciriacy [@bib23]; Hahn-Hägerdal *et al.*[@bib14]; Jeffries [@bib20]).

An alternative metabolic engineering strategy is based on redox-cofactor-independent isomerisation of [d]{.smallcaps}-xylose to [d]{.smallcaps}-xylulose by a heterologously expressed xylose isomerase (XI). Implementation of this strategy was long hindered by insufficient functional expression of heterologous XI genes, under physiologically relevant conditions, in *S. cerevisiae* (Walfridsson *et al.*[@bib70]). This situation changed when Kuyper *et al.* ([@bib26]) demonstrated functional expression of the *xylA* gene of the anaerobic fungus *Piromyces* sp. E2 in *S. cerevisiae* (Kuyper *et al.*[@bib26]). Multi-copy overexpression of *xylA*, combined with overexpression of the native xylulokinase gene (*XKS1*) and the major paralogs encoding enzymes of the non-oxidative PPP (*RKI1*, *RPE1*, *TAL1*, *TKL1*), enabled fast aerobic growth of *S. cerevisiae* on [d]{.smallcaps}-xylose (Kuyper *et al.*[@bib27]). This result has since been reproduced, both with *xylA* and with other heterologous XI genes, and in different *S. cerevisiae* genetic backgrounds (Table [1](#tbl1){ref-type="table"}). In many studies, this metabolic engineering strategy was combined with deletion of *GRE3*, which encodes a non-specific aldose reductase whose activity could lead to loss of carbon to xylitol (Träff *et al.*[@bib63]; Kuyper *et al.*[@bib26]; Kuyper *et al.*[@bib27]; Lee, Jellison and Alper [@bib30]). Moreover, accumulation of xylitol, a known inhibitor of XI enzymes (Yamanaka [@bib73]), might inhibit heterologously expressed XI activity.

###### 

Literature data on anaerobic growth of metabolically engineered, xylose-isomerase-based *S. cerevisiae* strains. The table summarises sets of targeted genetic modifications, aerobic-specific growth rates on [d]{.smallcaps}-xylose and any additional optimisation by laboratory evolution or mutagenesis required for anaerobic growth on [d]{.smallcaps}-xylose. NIA = no information available; \* specific growth rate estimated from exponential increase of CO~2~ concentration in bioreactor off gas.

  Strain background                         Strain                                               XI gene                                                                                            Native genes overexpressed                           Other targeted modifications                                                Aerobic growth rate (h^−1^)                                                 Anaerobic growth                                                                                                                                                                                                                                                                                                                                                                                                                             Reference
  ----------------------------------------- ---------------------------------------------------- -------------------------------------------------------------------------------------------------- ---------------------------------------------------- --------------------------------------------------------------------------- --------------------------------------------------------------------------- -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ---------------------------------------
  CEN.PK                                    RWB202                                               *Piromyces XylA* (2 micron plasmid)                                                                none                                                 No                                                                          0.005                                                                       After extensive aerobic, oxygen-limited and anaerobic selection (μ = 0.03 h^−1^)                                                                                                                                                                                                                                                                                                                                                             (Kuyper *et al.*[@bib26])
  CEN.PK                                    RWB217                                               *Piromyces XylA* (2 micron plasmid)                                                                *RKI1, RPE1, TAL1, TKL1 (all pTPI1), XKS1 (pADH1)*   *gre3Δ*                                                                     0.22                                                                        Anaerobic growth after ca. 35 h when inoculated at low cell densities (0.02 g biomass L^−1^, μ = 0.09 h^−1^). Immediate anaerobic growth when inoculated at high biomass concentration (0.2 g biomass L^−1^, μ = 0.09 h^−1^).                                                                                                                                                                                                                (Kuyper *et al.*[@bib27]), This study
  CEN.PK                                    YEp-opt.XI-Clos-K                                    *Clostridium phytofermentans*, codon optimised                                                     *XKS1, RKI1, RPE1, TAL1, TKL1*                       *GAL2* overexpression                                                       0.057                                                                       No                                                                                                                                                                                                                                                                                                                                                                                                                                           (Brat *et al.*[@bib4])
  CEN.PK                                    YEp-opt.XI-Piro                                      *Piromyces XylA*, codon-optimised                                                                  *XKS1, RKI1, RPE1, TAL1, TKL1*                       *GAL2* overexpression                                                       0.056                                                                       No                                                                                                                                                                                                                                                                                                                                                                                                                                           (Brat *et al.*[@bib4])
  BarraGrande (Industrial)                  BWY10Xyl                                             *Clostridium phytofermentans*, codon optimised                                                     NIA                                                  NIA                                                                         0.04                                                                        Serial aerobic shake flask cultures (6) on [d]{.smallcaps}-xylose until anaerobic xylose consumption observed upon aerobic biomass production.                                                                                                                                                                                                                                                                                               (Brat *et al.*[@bib4])
  CEN.PK                                    IMX696                                               *Piromyces XylA*, codon-optimised                                                                  *XKS1, RKI1, RPE1, TAL1, TKL1, NQM1, TKL2*           *gre3Δ*                                                                     0.21                                                                        After 12-day anaerobic adaptation phase (mutations in *PMR1*)                                                                                                                                                                                                                                                                                                                                                                                (Verhoeven *et al.*[@bib69])
  Ethanol Red (diploid)                     HDY.GUF5                                             *Clostridium phytofermentans*, codon-optimised                                                     *XKS1*, *RKI1, RPE1, TAL1, TKL1, TKL2, NQM1*         *HXT7*, *S. stipitis* AraA, *B. licheniformis* AraA, *E. coli* AraD, AraB   NIA                                                                         After extensive mutagenesis-, genome-shuffling and oxygen-limited selection experiments (no specific growth rates reported)                                                                                                                                                                                                                                                                                                                  (Demeke *et al.*[@bib7])
  Natural isolate (banana) YB-210/GLBRCY0   Y22--3 (haploid spore)                               *Clostridium phytofermentans XylA (ScTDH3p)*                                                       *-*                                                  *S. cerevisiae TAL1, S. stipitis XYL3*                                      NIA                                                                         No initial anaerobic growth observed. Aerobic selection in glucose--xylose media (34 transfers), anaerobic selection on same media (14 transfers). Evolved strain showed anaerobic growth in YPX medium (mutation in *GRE3* obtained).                                                                                                                                                                                                       (Parreiras *et al.*[@bib48])
  BF264--15Dau (Sun *et al.*[@bib60])       H131-A3                                              *Piromyces XylA*, codon-optimised (2 micron plasmid)                                               *RPE1, RKI1, TKL1*                                   *P. stipitis XKS1& TAL1*                                                    0.031 ± 0.022                                                               Aerobic cultivation in anaerobic sequential batch reactors (SBRs) on SMX (2% xylose; ca. 70 transfers), transfer to microaerobic SBRs (YNBX, 60 transfers), transfer to anaerobic SBRs (YNBX, 60 transfers), transfer to anaerobic chemostat with increasing dilution rate over time for ca. 60 generation (YNBX, d = 0.02 h^−1^ to 0.12 h^−1^), 20 more generations with YNBX with 10% xylose until dilution rate of 0.148 h^−1^.           (Zhou *et al.*[@bib76])
  CEN.PK                                    TMB3361                                              *Piromyces XylA* (2 micron plasmid)                                                                *TAL1, TKL1, RPE1, RKI1, XKS1 (all pPGK1)*           *E. coli* XK (*xylB*), *gre3Δ*                                              0.089 ± 0.002                                                               Anaerobic fermentations inoculated with very high cell densities (5 g L^−1^ CDW) resulting in partial conversion of the supplied xylose to ethanol (without an adaptation time) but without measurable growth (due to high initial cell densities).                                                                                                                                                                                          (Parachin *et al.*[@bib47])
  CEN.PK                                    YRH631 (naive), YRH1114 (evolved)                    *Prevotella ruminicola TC2--24 XI* (codon-optimised)                                               *XKS1*                                               No                                                                          0.06 (naive) 0.23 (evolved)                                                 Six transfers in microaerobic conditions (μ unknown).                                                                                                                                                                                                                                                                                                                                                                                        (Hector *et al.*[@bib16])
  INVSc1 (Invitrogen, USA)                  INVSc1/pRS406XKS/pILSUT1/pWOXYLA (XKS, Sut1, XylA)   *Orpinomyces xylA* (2 μm plasmid)                                                                  *XKS1*                                               *P. stipitis SUT1 over-expression*                                          NIA                                                                         CO~2~-flushed bottles inoculated with 5 g biomass L^−1^ showed consumption of 15.5 g L^−1^ xylose from a total of 50 g L^−1^ within 140 h.                                                                                                                                                                                                                                                                                                   (Madhavan *et al.*[@bib35])
  CEN.PK                                    TMB3066                                              *Piromyces XylA* (2 μm plasmid)                                                                    *TAL1, TKL1, RPE1, RKI1, XKS1 (all pPGK1*            *gre3Δ*                                                                     0.02                                                                        Anaerobic cultures resulting in partial conversion of the supplied xylose to ethanol (16.8 g of 50 g L^−1^ within 100 h, without an adaptation time) at high biomass density, no anaerobic growth reported.                                                                                                                                                                                                                                  (Karhumaa *et al.*[@bib21])
  CEN.PK                                    IMU078                                               *Piromyces XylA* (2 μm plasmid)                                                                    *TAL1, TKL1, RPE1, RKI1, NQM1, TKL2, XKS1*           *gre3Δ*                                                                     NIA                                                                         Anaerobic growth after ca. 7--8 d when inoculated at low biomass concentration (0.02 g biomass L^−1^), μ = ca. 0.09 h^−1^\*. Immediate anaerobic growth when (i) inoculated at high biomass density (0.2 g biomass L^−1^, μ = 0.05 h^−1^\*), (ii) upon supplementation with 0.1% CO~2~ in N~2~ used from sparging of bioreactors (μ = 0.05 h^−1^) or (iii) when [l]{.smallcaps}-aspartate is supplied as nitrogen source (μ = 0.05 h^−1^).   This study
  CEN.PK                                    IMU079                                               *Piromyces XylA* (2 μm plasmid)                                                                    *TAL1, TKL1, RPE1, RKI1, XKS1*                       *gre3Δ*                                                                     NIA                                                                         Anaerobic growth after ca. 40 h when inoculated at low cell densities (0.02 g biomass L^−1^, μ = 0.08 h^−1^). Immediate anaerobic growth when inoculated at high biomass concentration (0.2 g biomass L^−1^, μ = 0.07 h^−1^\*).                                                                                                                                                                                                              This study
  PE-2                                      LVY27 LVY34.4 (evolved) LVY41.5 (evolved)            *Orpinomyces sp. xylA* (codon-optimised; flanked with δ LTR sequences for high copy integration)   XKS1\*2, *TAL1, RKI1, TKL1, RPE1*                    *gre3Δ*                                                                     Very slow growth with 1 copy of *XylA*. Evolved: μ = 0.23 and 0.129 h^−1^   No anaerobic growth upon integration of one copy of *xylA.* Selection in semi-anaerobic conditions with 5 g L^−1^ glucose and 40 g L^−1^ xylose (12 transfers). Faster growth upon selection for increased *xylA* copy numbers, resulting in 36 and 26 copies.                                                                                                                                                                               (dos Santos *et al.*[@bib9])
  BY4741                                    BY4741-S2A3K                                         Mutated *Piromyces xylA3\** (2 μm plasmid)                                                         *XKS1*                                               *gre3Δ, S. stipitis TAL1* over-expression                                   0.061 h^−1^                                                                 Xylose fermentation possible in high cell density, micro-aerobic conditions (no growth rates available).                                                                                                                                                                                                                                                                                                                                     (Lee *et al.*[@bib30])
  BY4741                                    SXA-R2P                                              Mutated *Piromyces xylA3\** (2 copies; Lee *et al.*[@bib30])                                       *XKS1*                                               *gre3Δ, pho13 Δ, S. stipitis TAL1* over-expression (2 copies)               0.105 h^−1^ and 0.128 h^−1^ (evolved)                                       Naïve strain slowly consumed xylose in microaerobic conditions. Adaptive evolution in closed falcon tubes with media containing 20 g L^−1^ xylose (12 transfers). Evolved strain was capable of fast xylose consumption when inoculated at high biomass concentration in non-purged anaerobic bioreactors where initial oxygen was consumed within 12 h (no growth rates available).                                                         (Lee *et al.*[@bib31])
  CEN.PK                                    BSPC095                                              *Piromyces xylA* (2 μm plasmid)                                                                    *TAL1, TKL1, RPE1, RKI1, XKS1*                       *gre3Δ, cox4Δ*,                                                             No initial aerobic growth                                                   Weak aerobic growth observed in liquid xylose medium upon 10 days of aerobic incubation. Serial transfers of aerobic cultures with xylose during 1000 h resulted in aerobic growth rate of, μ = 0.11 h^−1^.                                                                                                                                                                                                                                  (Shen *et al.*[@bib57])

The literature is entirely consistent where it concerns aerobic growth on [d]{.smallcaps}-xylose of XI-based *S. cerevisiae* strains that carry the abovementioned genetic modifications. Conversely, reports on the ability of such strains to grow anaerobically on [d]{.smallcaps}-xylose appear to be conflicting. In their original paper, Kuyper *et al.* ([@bib27]) reported that *S. cerevisiae* RWB217, which was constructed in the CEN.PK genetic background (Entian and Kötter [@bib10]) and harboured the complete set of genetic modifications described above as well as a *gre3Δ* mutation, grew anaerobically on [d]{.smallcaps}-xylose in synthetic media without a need for additional mutagenesis or laboratory evolution (Kuyper *et al.*[@bib27]). However, when other groups constructed similar *S. cerevisiae* strains, anaerobic growth on [d]{.smallcaps}-xylose was reported to require additional laboratory evolution, mutagenesis and/or genetic engineering (Table [1](#tbl1){ref-type="table"}). Until recently, the different reported anaerobic growth performances of engineered *S. cerevisiae* strains might have been attributed to differences in strain background and/or XI genes (Table [1](#tbl1){ref-type="table"}). However, the recent single-step, CRISPR-Cas9-mediated construction of a [d]{.smallcaps}-xylose-metabolizing strain in the CEN.PK background, based on *Piromyces xylA*, yielded a strain that showed instantaneous, fast aerobic growth on [d]{.smallcaps}-xylose but reproducibly required a 12 day adaptation period before growth on [d]{.smallcaps}-xylose in anaerobic bioreactor cultures set in (Verhoeven *et al.*[@bib69]). Whole-genome resequencing showed that this adaptation reflected selection for mutants carrying mutations in *PMR1*, which encodes a Golgi Mn^2+^/Ca^2+^ ATPase. These mutations increased cellular contents of Mn^2+^, the preferred metal cofactor of XylA (Lee *et al.*[@bib29]; Verhoeven *et al.*[@bib69]). Since Verhoeven *et al.* ([@bib69]) used the same *S. cerevisiae* genetic background and XI gene as Kuyper *et al.* ([@bib27]), and, moreover, also overexpressed *XKS1* and PPP genes while deleting *GRE3* (Table [2](#tbl2){ref-type="table"}), their study raised questions on the genetic requirements for anaerobic [d]{.smallcaps}-xylose metabolism by CEN.PK-derived strains (Kuyper *et al.*[@bib27]; Verhoeven *et al.*[@bib69]).

###### 

*Saccharomyces cerevisiae* strains used in this study.

  Strain         Relevant genotype                                                                                                                       Description                                                                                                              Reference
  -------------- --------------------------------------------------------------------------------------------------------------------------------------- ------------------------------------------------------------------------------------------------------------------------ ---------------------------------
  CEN.PK113-7D   *MATa*                                                                                                                                  Reference strain                                                                                                         (Entian and Kötter [@bib10])
  CEN.PK113-5D   *MATa ura3*-*52*                                                                                                                        Uracil auxotrophic reference strain                                                                                      (Entian and Kötter [@bib10])
  CEN.PK102-3A   *MATA ura3*-*52 leu2*-*112*                                                                                                             Uracil and leucine auxotrophic strain                                                                                    (van Dijken *et al.*[@bib65])
  RWB217         CEN.PK102-3A *loxP-pTPI::(−266, −1)TAL1 gre3Δ::hphMX pUGpTPI-TKL1 pUGpTPI--RPE1 KanloxP--pTPI::(−40, −1)RKI1 {pAKX002, p415ADHXKS}*     Metabolically engineered, non-evolved xylose consuming strain                                                            (Kuyper *et al.*[@bib27])
  IMX975         RWB217 *can1::CAS9-tagA-loxP-natNT2-loxP*                                                                                               RWB217 expressing Cas9                                                                                                   This study
  IMX1366        IMX975, *sga1::pPGI1-NQM-TagB-pPYK1-TKL2*                                                                                               IMX975 over-expressing *NQM1* and *TKL2*                                                                                 This study
  IMX581         CEN.PK113--5D *can1::CAS9-tagA-loxP-natNT2-loxP*                                                                                        CEN.PK113--5D expressing *S. pyogenes* Cas9                                                                              (Mans *et al.*[@bib36])
  IMX696         IMX581 *gre3::pTDH3-RPE1- pPGK1-TKL1 -- pTEF1-TAL1- pPGI1-NQM1 -- pTPI1-RKI1 --pPYK1-TKL2-(pTPI1-xylA-tCYC1)\*36)-pTEF-XKS1*, pUDE335   IMX581 over-expressing PPP genes incl. *NQM1* and *TKL2*, expression of *Piromyces xylA* based on 36 integrated copies   (Verhoeven *et al.*[@bib69])
  IMX994         IMX581 *gre3::pTDH3-RPE1-tagH-pPGK1-TKL1-TagI-pTEF1-TAL1-TagA- pTPI1-RKI1-TagL- pTEF-XKS1*                                              IMX581 over-expressing genes from the non-oxidative pentose phosphate pathway                                            (Papapetridis *et al.*[@bib46])
  IMU079         IMX994, pAKX002 (2 μm *xylA*)                                                                                                           IMX994 over-expressing *xylA* from a 2 μm plasmid                                                                        (Papapetridis *et al.*[@bib46])
  IMX1456        IMX994*, sga1::pPGI1-NQM-TagB-pPYK1-TKL2*                                                                                               IMX994 over-expressing *NQM1* and *TKL2*                                                                                 This study
  IMU081         IMX1456, pAKX002 (2 μm *xylA*)                                                                                                          IMX1456 over-expressing *xylA* from a 2 μm plasmid                                                                       This study
  IMX800         IMX581, *gre3::pTDH3-RPE1-TagH-pPGK1-TKL1-TagI-pTEF1-TAL1-TagA-pPGI1-NQM1-TagB- pTPI1-RKI1-TagC-pPYK1-TKL2-TagL- pTEF-XKS1*             IMX581 over-expressing PPP genes incl. *NQM1* and *TKL2*                                                                 This study
  IMU078         IMX800, pAKX002 (2 μm *xylA*)                                                                                                           IMX800 over-expressing *xylA* from a 2 μm plasmid                                                                        This study
  IMX1736        IMU078, *pck1Δ*                                                                                                                         IMU078 with a deletion in *PCK1*                                                                                         This study

The goal of the present study was to critically re-examine and reproduce the genetic modifications required for anaerobic growth of *S. cerevisiae* on [d]{.smallcaps}-xylose reported by Kuyper *et al.* ([@bib27]) and Verhoeven *et al.* ([@bib69]). To this end, we constructed new engineered, [d]{.smallcaps}-xylose-fermenting strains to investigate the impact of subtle differences in strain construction strategies applied in the two studies. Subsequently, we compared growth of the resulting strains on [d]{.smallcaps}-xylose in anaerobic bioreactors, with special attention to the impact of inoculum density, initial carbon dioxide concentration and nitrogen source on anaerobic growth.

MATERIALS AND METHODS {#sec2}
=====================

Yeast strains and maintenance {#sec2-1}
-----------------------------

All *Saccharomycescerevisiae* strains used and constructed in this study belong to the CEN.PK lineage (Entian and Kötter [@bib10]; Nijkamp *et al.*[@bib41]; Salazar *et al.*[@bib53]). Yeast cultures were grown on synthetic medium (SM, prepared and sterilised as described previously (Verduyn *et al.*[@bib68])) or YP medium (10 g L^−1^ Bacto yeast extract (Becton Dickinson, Sparks, MD)), 20 g L^−1^ Bacto peptone (Becton Dickinson); autoclaved at 121°C for 20 min. SM was supplemented with 1 mL L^−1^ filter-sterilised vitamin solution (Verduyn *et al.*[@bib68]). Concentrated sterile [d]{.smallcaps}-glucose or [d]{.smallcaps}-xylose solutions (autoclaved at 110°C for 30 min) were added to SM and YP media to a concentration of 20 g L^−1^, resulting in SMD or SMX and YPD or YPX, respectively. Shake-flask cultures were grown in 500-mL round-bottom flasks containing 100 mL medium and incubated in an Innova incubator (Brunswick Scientific, Edison, NJ) at 30°C and 200 rpm. Solid media contained 2% (w/v) Bacto agar (Becton Dickinson). *Escherichia coli* strains were grown in LB-ampicillin medium (10 g L^−1^ Bacto tryptone, 5 g L^−1^ Bacto yeast extract, 5 g L^−1^ NaCl, 100 mg L^−1^ ampicillin). For storage, sterile glycerol was added to stationary-phase cultures of yeast and *E. coli* to a final concentration of 30% (v/v), after which aliquots were stored at −80°C.

Molecular biology {#sec2-2}
-----------------

Analytical PCR was performed with Dreamtaq polymerase (Thermo Scientific, Waltham, MA) according to the manufacturer\'s instructions. DNA fragments for cloning were amplified with Phusion Hot Start II High Fidelity Polymerase (Thermo Scientific, Waltham, MA) and with the desalted or PAGE-purified oligonucleotide primers (Sigma-Aldrich, St. Louis, MO) listed in Table S1, Supporting Information. DNA fragments were separated by gel electrophoresis (90 V, 35 min) on 1% (w/v) agarose gels (Thermo Scientific) buffered with 1× TAE (Thermo Scientific). When required, DNA fragments were excised from gels and purified with a Zymoclean Gel DNA Recovery Kit (Zymo Research, Irvine, CA) or, when no unspecific products were detected, directly purified from the PCR mix with a GenElute PCR Clean-Up Kit (Sigma-Aldrich). Yeast genomic DNA was extracted with a YeaStar Genomic DNA kit (Zymo Research) and DNA for diagnostic colony PCR was extracted by boiling cells picked from colonies in 10 μL 0.2 N NaOH for 5 min. After removal of debris by centrifugation (1 min at 2000 × *g*), 2 μL of the supernatant was used as template in a 20 μL PCR reaction (Dreamtaq). Yeast and *E. coli* plasmids were extracted with a Zymoprep Yeast Plasmid Miniprep II kit (Zymo Research, Irvine, CA) and with a Sigma GenElute Plasmid kit (Sigma-Aldrich), respectively. Yeast transformation was carried out with the lithium-acetate method (Gietz and Woods [@bib12]). When *natNT2* was used as a marker gene, the transformation procedure included an overnight incubation step in non-selective liquid media (SMG) prior to selection on solid SMG plates containing 1 g L^−1^ glutamic acid as the sole nitrogen source, which were supplemented with 100 mg L^−1^ nourseothricin (pH 6). Single-colony isolates were obtained by three consecutive re-streaks on solid selective medium and genotype confirmation by analytical PCR. *Escherichiacoli* DH5α was used for chemical transformation (Inoue, Nojima and Okayama [@bib18]) or electroporation in 2 mm cuvettes (165-2086, Bio-Rad, Hercules, CA) using a Gene Pulser Xcell Electroporation system (Biorad). Isolated plasmids were routinely checked by analytical PCR and restriction analysis.

Strain and plasmid construction {#sec2-3}
-------------------------------

Detailed genotypes of all strains and plasmids used or generated in this study are listed in Tables [2](#tbl2){ref-type="table"} and [3](#tbl3){ref-type="table"}, respectively. Genomic DNA of *S. cerevisiae* CEN.PK113-7D was used as a template for amplification of *S. cerevisiae* gene-, promoter- and terminator fragments. The CEN.PK strain lineage and construction of the derived *S. cerevisiae* strains RWB217, IMX581, IMX994 and IMU079 are described elsewhere (Kuyper *et al.*[@bib27]; Entian and Kötter [@bib10]; Mans *et al.*[@bib36]; Papapetridis *et al.*[@bib46]). Integration of overexpression cassettes for *NQM1* and *TKL2* (pPGI1-*NQM1*-TagB-pPYK1-*TKL2*) was achieved by targeted integration into IMX994 using 60 bp flanks homologous to *SGA1*. Fragments were obtained by amplification of the SGA1flank-pPGI1-*NQM1*-TagB-cassette from pUD344 using primers 11357 and 3276 and amplification of the TagB-pPYK1-*TKL2*-SGA1flank-cassette from pUD346 using primer pair 11356 and 7607. Both fragments were co-transformed with pUDR103, a plasmid expressing a gRNA targeting *SGA1*, into IMX994. pUDR103 was subsequently counter selected by non-selective growth in YPD medium followed by plating on solid SMG plates supplemented with uracil and 5-fluoroorotic acid (0.15 and 1 g L^−1^ final concentration, respectively), resulting in strain IMX1456 (IMX994 *sga1::NQM1, TKL2*). This strain was subsequently transformed with the *xylA* plasmid pAKX002, resulting in strain IMU081. Construction of strain IMX800 (IMX581 *gre3::RPE1, TKL1, NQM1, RKI1, TKL2, XKS1*) was similar to the construction of strain IMX994 (IMX581 *gre3::RPE1, TKL1, TAL1, RKI1, XKS1*; Papapetridis *et al.*[@bib46]) with the difference that, in the former strain, the chromosomally integrated cluster of overexpression cassettes for pentose-phosphate-pathway genes included *NQM1* and *TKL2.* The expression cassette for *TAL1* was amplified from pUD349 with primer pair 3274 and 3275, yielding the tag-flanked expression cassette TagI-pTEF1-*TAL1*-TagA; *NQM1* was amplified from pUD344 with primers 3847 and 3276 to yield the expression cassette TagA-pPGI1-*NQM1*-TagB; the TagB-pTPI1-*RKI1*-TagC cassette was amplified from pUD345 with primers 4672 and 3277; the TagC-pPYK1-*TKL2*-TagL cassette was amplified from pUD346 with primers 3283 and 8285 and the TagL-pTEF-*XKS1*-GRE3flank cassette was amplified from pUD353 with the primer pair 7222 and 7135. In overexpression cassettes, *S. cerevisiae* genes retained their endogenous terminators. Transformation of strain IMX800 with the high-copy-number *xylA* plasmid pAKX002, which was isolated from *S. cerevisiae* RWB217 (Kuyper *et al.*[@bib27]), yielded strain IMU078. *PCK1* was deleted in strain IMU078 according to the protocol described by Mans *et al.* ([@bib36]), resulting in strain IMX1736 (Mans *et al.*[@bib36]). Two plasmid fragments were transformed directly into IMU078 for *in vivo* assembly: a 2 μm fragment amplified from pROS13 with a double-binding primer adding a gRNA flank guiding a cut in *PCK1* (primer 14234) and a backbone harbouring a *kanMX* marker amplified from pROS13 using the double-binding primer 6005. Plasmid fragments were transformed together with an annealed double-strand repair fragment (oligonucleotide 14235 and 14236) homologous to 60 bp up- and downstream of *PCK1* to delete the ORF. Mutants were selected on solid YPD plates supplemented with 200 mg L^−1^ G418. Primer pair 14237 and 14238 was used to screen for positive colonies. A positive colony was grown in non-SMG, plated on solid SMG and subsequently replica-plated on solid SMG and YPD-G418 plates to check for successful plasmid loss. Cells from a colony that lost the G418-marker harbouring plasmid were double checked for a *pck1Δ* genotype and subsequently stocked as strain IMX1736. To enable CRISPR-Cas9-based editing of RWB217, a *cas9-*cassette with a *can1-* and a TagA- overhang amplified from p414 (DiCarlo *et al.*[@bib8]) with primers 2873 and 3093 and a *natNT2* cassette with the same tags, amplified from pROS15 (Mans *et al.*[@bib36]) with primers 4653 and 5542 was integrated into the *CAN1* locus by homologous recombination, resulting in strain IMX975. Integration of *sga1::NQM1*, *TKL2* into IMX975, resulting in strain IMX1366 (IMX975 *sag1::NQM1, TKL2*) was done as described for strain IMU081 with the difference that the gRNA plasmid pUDR119 with an *amdSYM* marker was used and no pAKX002 plasmid had to be transformed due to its presence in IMX975. Selection and counter selection of the *amdSYM* marker cassette were performed as described previously (Solis-Escalante *et al.*[@bib59]). *PMR1* genes, including promoters and terminators, were amplified from duplicate 200 h anaerobic bioreactor cultures of strain IMU078, with primer pair 8790 and 8791 and subsequently Sanger sequenced (BaseClear, Leiden, The Netherlands) with primers 8790, 8791 and 13459--13475.

###### 

Plasmids used in this study.

  Name                       Relevant characteristics                                          Reference
  -------------------------- ----------------------------------------------------------------- ---------------------------------
  pROS15                     2 μm ampR *natNT2* gRNA-*CAN1.*Y gRNA-*ADE2.*Y                    (Mans *et al.*[@bib36])
  pROS11                     2 μm ampR *amdSYM* gRNA-*CAN1.*Y gRNA-*ADE2.*Y                    (Mans *et al.*[@bib36])
  pROS13                     2 μm ampR *kanMX* gRNA-*CAN1.*Y gRNA-*ADE2.*Y                     (Mans *et al.*[@bib36])
  pAKX002                    2 μm, *URA3, pTPI1-XylA* (*Piromyces spp.* E2)                    (Kuyper *et al.*[@bib26])
  p414 -*pTEF1-Cas9-tCYC1*   *CEN6/ARS4* ampR *pTEF1-cas9-tCYC1*                               (DiCarlo *et al.*[@bib8])
  pMEL10                     2 μm, *KlURA3, pSNR52-*gRNA.*CAN1*.Y-*tSUP4*                      (Mans *et al.*[@bib36])
  pJET1.2Blunt               Multi-purpose cloning vector for storage of assembled cassettes   ThermoFisher
  pUD344                     pJET1.2Blunt TagA-*pPGI1-NQM1*-*tNQM1*-TagB                       (Verhoeven *et al.*[@bib69])
  pUD345                     pJET1.2Blunt TagB-*pTPI1-RKI1-tRKI1*-TagC                         (Verhoeven *et al.*[@bib69])
  pUD346                     pJET1.2Blunt TagC-*pPYK1-TKL2-tTKL2*-TagF                         (Verhoeven *et al.*[@bib69])
  pUD347                     pJET1.2Blunt TagG-*pTDH3-RPE1-tRPE1*-TagH                         (Verhoeven *et al.*[@bib69])
  pUD348                     pJET1.2Blunt TagH*-pPGK1-TKL1-tTKL1-*TagI                         (Verhoeven *et al.*[@bib69])
  pUD349                     pJET1.2Blunt TagI*-pTEF1-TAL1-tTAL1*-TagA                         (Verhoeven *et al.*[@bib69])
  pUD350                     pJET1.2Blunt *pTPI1-XylA-tCYC1*                                   (Verhoeven *et al.*[@bib69])
  pUD353                     pJET1.2Blunt *pTEF1-XKS1-tXKS1*                                   (Verhoeven *et al.*[@bib69])
  pUDE335                    2 μm ori, *KlURA3, pSNR52*-gRNA.*GRE3*.Y-*tSUP4*                  (Verhoeven *et al.*[@bib69])
  pUDR119                    2 μm, *amdSYM, pSNR52-*gRNA.*SGA1.*Y-*tSUP4*                      (van Rossum *et al.*[@bib66])
  pUDR103                    2 μm, *KlURA3, pSNR52-*gRNA.*SGA1.*Y-*tSUP4*                      (Papapetridis *et al.*[@bib45])

Bioreactor cultivation {#sec2-4}
----------------------

*Saccharomyces* *cerevisiae* strains were physiologically characterised in anaerobic 2 L laboratory bioreactors (Applikon, Delft, The Netherlands) with a 1 L working volume. Bioreactors filled with SM were autoclaved at 121°C for 20 min. SM with [l]{.smallcaps}-aspartate as nitrogen source was prepared as described previously (Zelle *et al.*[@bib75]) and filter sterilised (Nalgene Rapid-Flow, 0.2 μm, Thermo Scientific) prior to addition to autoclaved bioreactors. Separately prepared solutions were subsequently added to final concentrations of 20 g L^−1^[d]{.smallcaps}-xylose, 1 mL L^−1^ vitamin solution, 0.2 g L^−1^ antifoam C, as well as 10 and 420 mg L^−1^ of the anaerobic growth factors ergosterol and Tween-80, respectively. Cultures were sparged with nitrogen (0.5 L min^−1^) to maintain anaerobic conditions. For physiological characterisation of strain IMU078 with CO~2~ supplementation, nitrogen as a sparging gas was replaced by an analytically certified (2% tolerance) mixture of 99.9% N~2~ and 0.1% CO~2~ (Linde Group, Munich, Germany). Oxygen diffusion into bioreactors was minimised by equipping them with Norprene tubing (Saint-Gobain, Courbevoie, France) and Viton O-rings (Eriks, Alkmaar, The Netherlands). Evaporation was minimised by cooling the outlet gas to 4°C. Cultures were stirred at 800 rpm, maintained at pH 5 by automatic addition of 2 M KOH and kept at 30°C. Separate inocula were prepared for each bioreactor. These inocula were obtained by growth of the respective strain, starting with a frozen stock culture, in two consecutive aerobic 100 mL shake flask cultures on SMX, at 30°C and 200 rpm. When the OD~660~ of the pre-cultures was between 3.5 and 5.5, they were used to inoculate the anaerobic bioreactors. The initial OD~660~ of bioreactor cultures was either 0.1 or 1 (0.02 or 0.2 g biomass L^−1^, respectively) as indicated.

Analytical techniques {#sec2-5}
---------------------

Biomass dry weight measurements and optical density measurements at a wavelength of 660 nm were performed as described previously (Verhoeven *et al.*[@bib69]). A correlation between biomass dry weight concentration and optical density, based on at least 10 measurement points during the exponential growth phase, was used to estimate the biomass concentrations for the first few bioreactor culture samples, when the cell density was too low to allow for accurate biomass dry weight determinations (OD~660~ \< 0.9). Specific growth rates were calculated from at least six biomass dry-weight measurements during the exponential growth phase. Concentrations of biomass, ethanol, glycerol and [d]{.smallcaps}-xylose, at the same sampling times, were used to calculate yields (gram product per gram xylose) from the slopes of the linear [d]{.smallcaps}-xylose concentration decrease versus the concentrations of the respective metabolites or biomass dry weight as described previously (Papapetridis *et al.*[@bib44]). CO~2~ and O~2~ concentrations in the exhaust gas of bioreactors and metabolite concentrations were measured as described previously (Verhoeven *et al.*[@bib69]).

RESULTS {#sec3}
=======

Genetic requirements for anaerobic growth on xylose {#sec3-1}
---------------------------------------------------

*Saccharomyces* *cerevisiae* RWB217 was the first XI-based engineered yeast strain that was reported to grow anaerobically on [d]{.smallcaps}-xylose without prior laboratory evolution or mutagenesis (Kuyper *et al.*[@bib27]; Fig. [1A](#fig1){ref-type="fig"}). Recently, anaerobic growth on [d]{.smallcaps}-xylose of a strain that was newly reconstructed in the same genetic background and contained a similar set of genetic modifications (strain IMX696 (Verhoeven *et al.*[@bib69]), Table [2](#tbl2){ref-type="table"}) was reported to require mutations in *PMR1*. In view of this apparent discrepancy and other literature reports on additional genetic requirements for anaerobic growth of [d]{.smallcaps}-xylose-metabolising strains in other genetic backgrounds (Table [1](#tbl1){ref-type="table"}), we re-investigated the requirement for anaerobic growth of CEN.PK-based *S. cerevisiae* strains.

![Fermentation profiles, indicated as percentage of CO~2~ in off gas over time, of metabolically engineered, non-evolved [d]{.smallcaps}-xylose-metabolizing *S. cerevisiae* strains grown in anaerobic bioreactor batch cultures on SM supplemented with 20 g L^−1^[d]{.smallcaps}-xylose. Unless indicated otherwise, cultures were inoculated at a biomass concentration of 0.02 g L^−1^ and sparged with 0.5 vvm N~2~. (**A**) Strain RWB217 (*gre3Δ, RPE1↑, RKI1↑, TAL1↑, TKL1*↑, *XKS1↑*, *xylA* (pAKX002); Kuyper *et al.*[@bib27]). (**B**) Strain IMU078 (*gre3Δ, RPE1↑, RKI1↑, TAL1↑, TKL1↑, NQM1↑, TKL2↑*, *XKS1↑*, *xylA* (pAKX002)). (**C**) Strain IMU078 inoculated at 0.2 g biomass L^−1^. (**D**) Strain IMU078 inoculated at 0.02 g biomass L^−1^ and sparged with a mixture of 99.9% N~2~ and 0.1% CO~2~ at 0.5 vvm. (**E**) Strain IMU078 inoculated at 0.02 g biomass L^−1^ in media containing [l]{.smallcaps}-aspartate as nitrogen source instead of ammonium sulfate. Sampling of this culture for metabolite analyses (Fig. [2C](#fig2){ref-type="fig"}) affected the CO~2~ profile. (**F**) Strain IMX1736 (IMU078 *pck1*Δ) inoculated at 0.02 g biomass L^−1^ and sparged with a mixture of 99.9% N~2~ and 0.1% CO~2~ at 0.5 vvm The panels show results from 4 (panel B, D), 3 (panel A) and 2 (panel C, E, F) independent experiments, respectively. Detailed information on strain genotypes is provided in Table [2](#tbl2){ref-type="table"}.](foy104fig1){#fig1}

While, in strain RWB217 as well as in strain IMX696, *xylA* was expressed from the *TPI1* promoter, the *xylA* coding region was codon optimised in strain IMX696 (Verhoeven *et al.*[@bib69]) but not in strain RWB217 (Kuyper *et al.*[@bib27]). Moreover, in strain IMX696 the *xylA* expression cassettes were chromosomally integrated, resulting in ca. 36 copies per haploid genome (Verhoeven *et al.*[@bib69]), whereas the *xylA* expression cassette in strain RWB217 was expressed from a multi-copy episomal vector (Kuyper *et al.*[@bib27]). To investigate whether these differences affected anaerobic growth on [d]{.smallcaps}-xylose of these two strains, a new strain was constructed that carried the same set of genetic modifications as strain IMX696 but expressed *xylA* from the same episomal vector (pAKX002) as strain RWB217. Growth on [d]{.smallcaps}-xylose of the resulting strain, IMU078 (*gre3Δ, RPE1↑, RKI1↑, TAL1↑, TKL1↑, NQM1↑, TKL2↑*, *XKS1↑;* pAKX002 (2 μm *xylA*)), was investigated in anaerobic, nitrogen-sparged bioreactor cultures, exactly as described previously (Verhoeven *et al.*[@bib69]). In these cultures, strain IMU078 showed a 7--8 day adaptation phase before anaerobic growth on [d]{.smallcaps}-xylose set in (Fig. [1B](#fig1){ref-type="fig"}). Under the same conditions, strain RWB217 showed anaerobic growth on [d]{.smallcaps}-xylose within 32 ± 6 h after inoculation (Fig. [1A](#fig1){ref-type="fig"}), consistent with the original report by Kuyper *et al.* ([@bib27]). These results indicate that codon usage and/or mode of *xylA* overexpression were not decisive factors in causing the presence and absence of a prolonged anaerobic adaptation phase in strains IMX696 (Verhoeven *et al.*[@bib69]) and RWB217 (Kuyper *et al.*[@bib27]), respectively. To check if the integrated Cas9 expression cassette that was present in strains IMX696 and IMU078 but not in RWB217 affected anaerobic growth on [d]{.smallcaps}-xylose, the Cas9 cassette was integrated at the *CAN1* locus of strain RWB217, yielding strain IMX975. This strain exhibited the same anaerobic growth profile as strain RWB217 (Fig. [2A](#fig2){ref-type="fig"}).

![Growth and product formation in anaerobic bioreactor cultures of metabolically engineered, non-evolved, [d]{.smallcaps}-xylose-metabolizing *S. cerevisiae* strains. Cultures were inoculated at a biomass concentration of 0.02 g L^−1^ and, unless otherwise stated, were sparged with 0.5 vvm N~2~. (**A**) Strain IMX975 (RWB217 (*gre3Δ, RPE1↑, RKI1↑, TAL1↑, TKL1↑*, *XKS1↑*, *xylA* (pAKX002), *can1::Cas9*)). (**B**) Strain IMU078 (*gre3Δ, RPE1↑, RKI1↑, TAL1↑, TKL1↑, NQM1↑, TKL2↑*, *XKS1↑*, *xylA* (pAKX002)) sparged with 0.5 vvm of a mixture of 0.1% CO~2~ and 99.9% N~2~. (**C**) Strain IMU078 grown in media containing [l]{.smallcaps}-aspartate as nitrogen source instead of ammonium sulfate. ● = [d]{.smallcaps}-Xylose; ▪ = Biomass; ■ = Glycerol; ○ = Ethanol; Δ = Acetate. The panels show data from single representative cultures from a set of two independent duplicate cultures for each strain. Data from replicate cultures are shown in Supplemental Fig. S1, Supporting Information.](foy104fig2){#fig2}

When, after 12 days, replicate anaerobic bioreactor cultures of strain IMU078 on [d]{.smallcaps}-xylose had reached stationary phase, their *PMR1* loci were PCR amplified and Sanger sequenced. In contrast to observations in similar experiments with strain IMX696 (Verhoeven *et al.*[@bib69]), no mutations were found in promoter, terminator or coding region of *PMR1.* This result suggested that other mutations were responsible for the eventual anaerobic growth on [d]{.smallcaps}-xylose of strain IMU078*.*

Inoculum density and resulting initial CO~2~ concentration affect anaerobic growth on [d]{.smallcaps}-xylose {#sec3-2}
------------------------------------------------------------------------------------------------------------

In the original characterisation of strain RWB217 in anaerobic batch cultures (Kuyper *et al.*[@bib27]), an inoculum concentration of 0.2 g biomass L^−1^ was used. The experiments discussed above and the previous characterisation of strain IMX696 (Verhoeven *et al.*[@bib69]) were inoculated with a 10-fold lower inoculum density. Use of a 0.2 g L^−1^ inoculum density completely abolished the 7--8 day adaptation phase of strain IMU078 (*gre3Δ, RPE1↑, RKI1↑, TAL1↑, TKL1↑, NQM1↑, TKL2↑*, *XKS1↑;* pAKX002 (2 μm *xylA*)) in anaerobic, [d]{.smallcaps}-xylose-grown batch cultures (Fig. [1C](#fig1){ref-type="fig"}). The specific growth rates of these cultures on [d]{.smallcaps}-xylose, estimated from CO~2~ concentrations in the outlet gas were, however, lower than those eventually reached by low-inoculum-density cultures after adaptation to anaerobic growth on [d]{.smallcaps}-xylose (0.04 ± 0.00 h^−1^ and 0.10 ± 0.01 h^−1^, respectively).

The anaerobic bioreactor cultures in this study were sparged with N~2~ (0.5 L min^−1^). As was to be expected, inoculum density positively correlated with initial CO~2~ concentrations in the off gas of the cultures and therefore, by inference, with concentrations of CO~2~ in the culture broth (Fig. [1A--F](#fig1){ref-type="fig"}). In cultures of strain IMU078 inoculated at 0.02 g biomass L^−1^, the initial CO~2~ content in the off gas was 0.004% ± 0.001%, as compared to 0.04% ± 0.005% in cultures started at a 10-fold higher biomass concentration. To investigate whether the initial CO~2~ concentration influenced the onset of anaerobic growth on [d]{.smallcaps}-xylose, anaerobic bioreactor cultures of strain IMU078 (*gre3Δ, RPE1↑, RKI1↑, TAL1↑, TKL1↑, NQM1↑, TKL2↑*, *XKS1↑;* pAKX002 (2 μm *xylA*)), inoculated at 0.02 g biomass L^−1^, were sparged with a mixture of 0.1% CO~2~ and 99.9% N~2~ instead of with pure N~2~. This change, which led to an initial CO~2~ concentration in the outlet gas of 0.1%, abolished the 7--8 d lag phase observed for this strain in low-inoculum-density cultures sparged with pure N~2~ (Figs [1D](#fig1){ref-type="fig"} and [2B](#fig2){ref-type="fig"}). These results indicate that anaerobic growth of engineered, [d]{.smallcaps}-xylose-metabolizing *S. cerevisiae* can strongly depend on the concentration of CO~2~.

Use of [l]{.smallcaps}-aspartate as nitrogen source can replace CO~2~ supplementation in low-inoculum-density cultures of strain IMU078 {#sec3-3}
---------------------------------------------------------------------------------------------------------------------------------------

As recently proposed for xylose-fermenting *E. coli* (Gonzalez, Long and Antoniewicz [@bib13]), the observed CO~2~ requirement of engineered *S. cerevisiae* strains for anaerobic growth on [d]{.smallcaps}-xylose might reflect a pivotal role of the anaplerotic carboxylation of pyruvate or phosphoenolpyruvate (PEP) to oxaloacetate. To test this hypothesis, strain IMU078 (*gre3Δ, RPE1↑, RKI1↑, TAL1↑, TKL1↑, NQM1↑, TKL2↑*, *XKS1↑;* pAKX002 (2 μm *xylA*)) was grown on [d]{.smallcaps}-xylose in low-inoculum density (0.02 g biomass L^−1^) bioreactor cultures sparged with pure N~2~, in which [l]{.smallcaps}-aspartate instead of ammonium sulfate was used as the sole nitrogen source. In cultures grown on [l]{.smallcaps}-aspartate, which can be directly transaminated to oxaloacetate in a CO~2~-independent manner, strain IMU078 showed immediate anaerobic growth (Figs [1E](#fig1){ref-type="fig"} and [2C](#fig2){ref-type="fig"}).

In *S. cerevisiae*, oxaloacetate can be formed from pyruvate by pyruvate carboxylase (Pyc1, Pyc2) or via PEP-carboxykinase (Pck1). *PCK1* expression is repressed by glucose (Gancedo and Schwerzmann [@bib11]; Daran-Lapujade *et al.*[@bib6]) and elevated concentrations of CO~2~ are required to enable Pck1 to act as sole anaplerotic enzyme in *S. cerevisiae* (Zelle *et al.*[@bib75]). A previous transcriptome study on an evolved XI-based, xylose-fermenting strain showed an 8-fold higher transcript level of *PCK1* than its non-evolved parental strain (Zhou *et al.*[@bib76]). However, deletion of *PCK1* in strain IMU078 (*gre3Δ, RPE1↑, RKI1↑, TAL1↑, TKL1↑, NQM1↑, TKL2↑*, *XKS1↑*, pAKX002 (2 μm *xylA*)), resulting in strain IMX1736 (IMU078, *pck1Δ*), did not abolish the positive effect of external CO~2~ supplementation on anaerobic growth on [d]{.smallcaps}-xylose (Fig. [1F](#fig1){ref-type="fig"}).

Omitting the over-expression of PPP paralogs enables lag-phase free anaerobic xylose fermentation at low inoculum density {#sec3-4}
-------------------------------------------------------------------------------------------------------------------------

In addition to codon-optimisation and *xylA* expression vector, a third genetic difference exists between RWB217 (*gre3Δ, RPE1↑, RKI1↑, TAL1↑, TKL1↑*, *XKS1↑;* pAKX002 (2 μm *xylA*); Kuyper *et al.*[@bib27]; Table [2](#tbl2){ref-type="table"}) and the two strains requiring a multi-day anaerobic adaptation phase prior to xylose fermentation (IMX696 (*gre3Δ, RPE1↑, RKI1↑, TAL1↑, TKL1↑, NQM1↑, TKL2↑*, *XKS1↑*, *xylA\*36* (Verhoeven *et al.*[@bib69]) and IMU078 (*gre3Δ, RPE1↑, RKI1↑, TAL1↑, TKL1↑, NQM1↑, TKL2↑*, *XKS1↑*, pAKX002 (2 μm *xylA*), Table [2](#tbl2){ref-type="table"}). This difference concerns the over-expression of minor paralogs of the PPP genes *TAL1* and *TKL1* (*NQM1* and *TKL2*, respectively) in the latter two strains. To evaluate the potential impact of the presence of expression cassettes for *NQM1* and *TKL2* in strains IMX696 and IMU078, a strain was constructed that was congenic to IMU078 except for the omission of the expression cassettes corresponding to *NQM1* and *TKL2* in the synthetic gene cluster harbouring the genes encoding non-oxidative PPP enzymes and *XKS1* (Table [2](#tbl2){ref-type="table"}). Although the topology of the expression cassettes was different, the relevant genotype of the resulting strain IMU079 (*gre3Δ, RPE1↑, RKI1↑, TAL1↑, TKL1↑, XKS1↑;* pAKX002 (2 μm *xylA*), Table [2](#tbl2){ref-type="table"}) mimicked that of strain RWB217. Just like strain RWB217, strain IMU079 initiated anaerobic growth on [d]{.smallcaps}-xylose within 35 ± 5 h in low-inoculum-density, nitrogen-sparged cultures grown with ammonium sulfate as nitrogen source (Fig. [3A and B](#fig3){ref-type="fig"}). Furthermore, specific growth rate and other physiological parameters of strain IMU079 were similar to those of the Cas9-expressing strain derived from RWB217 (IMX975, Table [4](#tbl4){ref-type="table"}). When inoculated at a high cell density (0.2 g biomass L^−1^), strains IMU079 and IMU078 showed closely corresponding CO~2~ production profiles (Supplementary Fig. S3, Supporting Information).

![Fermentation profiles of the metabolically engineered, non-evolved [d]{.smallcaps}-xylose metabolizing *S. cerevisiae* strain IMU079 (*gre3Δ, RPE1↑, RKI1↑, TAL1↑, TKL1↑*, *XKS1↑*, *xylA* (pAKX002)) grown in anaerobic bioreactor batch cultures on SM supplemented with 20 g L^−1^[d]{.smallcaps}-xylose. Cultures were inoculated at a biomass concentration of 0.02 g L^−1^ and sparged with 0.5 vvm N~2~. (**A**) CO~2~ concentration in off gas. (**B**) Growth and product formation. ● = [d]{.smallcaps}-Xylose; ▪ = Biomass; ■ = Glycerol; ○ = Ethanol; Δ = Acetate. Panel (A) shows data from duplicate cultures, panel (B) shows data from a single representative culture from a set of two independent duplicate cultures. Data from replicate cultures are shown in Supplemental Fig. S2, Supporting Information.](foy104fig3){#fig3}

###### 

Specific growth rates and yields of biomass, ethanol and glycerol of the metabolically engineered, xylose-fermenting *S. cerevisiae* strains IMX975 (RWB217-Cas9 (*gre3Δ, RPE1↑, RKI1↑, TAL1↑, TKL1↑*, *XKS1↑*, *can1::CAS9*, 2 μm *xylA* (pAKX002)), IMU079 (*gre3Δ, RPE1↑, RKI1↑, TAL1↑, TKL1↑*, *XKS1↑*, 2 μm *xylA* (pAKX002)) and IMU078 (*gre3Δ, RPE1↑, RKI1↑, TAL1↑, TKL1↑, NQM1↑, TKL2↑*, *XKS1↑*, 2 μm *xylA* (pAKX002)) in anaerobic bioreactor batch cultures, inoculated with an initial biomass density of 0.02 g biomass L^−1^ and grown on 20 g L^−1^ xylose. Bioreactor cultures of strains IMX975, IMU079 and IMU078 ([l]{.smallcaps}-Asp) were sparged with pure N~2~ (0.5 vvm). Cultures of strain IMU078 indicated as 'IMU078 (+0.1% CO~2~)' were sparged with a mixture of 0.1% CO~2~ and 99.9% N~2~. '[l]{.smallcaps}-Asp' indicates that the medium contained [l]{.smallcaps}-aspartate instead of ammonium sulfate as sole nitrogen source. Data represent average ± SE of two independent cultures for each strain. Detailed information on strain genotypes is provided in Table [2](#tbl2){ref-type="table"}.

                                 IMX975          IMU079          IMU078 (+ 0.1% CO~2~)   IMU078 ([l]{.smallcaps}-Asp)
  ------------------------------ --------------- --------------- ----------------------- ------------------------------
  Specific growth rate (h^−1^)   0.09 ± 0.01     0.08 ± 0.00     0.05 ± 0.01             0.054 ± 0.001
  Biomass yield (g g^−1^)        0.088 ± 0.001   0.096 ± 0.004   0.093 ± 0.002           0.104 ± 0.002
  Ethanol yield (g g^−1^)        0.395 ± 0.013   0.395 ± 0.002   0.382 ± 0.003           0.406 ± 0.002
  Glycerol yield (g g^−1^)       0.085 ± 0.001   0.081 ± 0.001   0.074 ± 0.003           0.076 ± 0.000

To further investigate the effects of over-expression of *NQM1* and/or *TKL2* on anaerobic growth on [d]{.smallcaps}-xylose, over-expression cassettes for *NQM1* and *TKL2* were introduced in the *SGA1* loci of strains IMX975 (RWB217, *can1::Cas9*) and IMU079, neither of which previously harboured these cassettes*.* However, characterisation of the resulting strains (IMU081 (IMU079 *sga1*::*NQM1,TKL2*), IMX1366 (IMX975 *sga1*::*NQM1,TKL2*)) in anaerobic bioreactor cultivations with xylose led to inconsistent lag-phase phenotypes (Supplementary Fig. S4, Supporting Information). In particular, introduction of the two cassettes in strains IMX975 (RWB217, *can1::Cas9*) and IMU079 did not yield prolonged anaerobic adaptation phases. These observations indicate that the effect of these cassettes on anaerobic growth may be related to or even caused by their immediate genetic context, e.g. by affecting expression of neighbouring genes in the pentose-pathway gene cluster in strains IMX696 and IMU078.

DISCUSSION {#sec4}
==========

Repeatability of results is a key requirement for progress in all scientific research (Nature [@bib39]). This reassessment of requirements for anaerobic growth on [d]{.smallcaps}-xylose of engineered, XI-based *Saccharomycescerevisiae* strains was prompted by results from multiple laboratories, including our own (Table [1](#tbl1){ref-type="table"}), which appeared to contradict an early report by our group (Kuyper *et al.*[@bib27]). The results confirm the conclusions of Kuyper *et al.* ([@bib27]) by showing that the defined set of targeted genetic modifications reported in their study suffices to enable anaerobic growth of CEN.PK-based strains on [d]{.smallcaps}-xylose. Additionally, this study shows how anaerobic growth on [d]{.smallcaps}-xylose can critically depend on seemingly small differences in strain design and cultivation conditions.

Verhoeven *et al.* ([@bib69]) included overexpression of *NQM1* and *TKL2*, the 'minor' paralogs of the PPP genes *TAL1* and *TKL1*, respectively, in their strategy for single-step construction of a xylose-metabolising *S. cerevisiae* strain. Increased expression of these paralogs in evolved strains had previously been shown to contribute to improved anaerobic growth [l]{.smallcaps}-arabinose (Wisselink *et al.*[@bib72]), whose metabolism also proceeds via the non-oxidative PPP. This study shows that the mere omission of these two overexpression cassettes from the strain design of Verhoeven *et al.* ([@bib69]) suffices to eliminate a prolonged (12 d) adaptation phase prior to initiation of anaerobic growth on [d]{.smallcaps}-xylose in N~2~-sparged cultures grown at a low inoculum density.

A recent study showed reduced protein levels of Tkl2 and Nqm1 in *xylA*-based strains evolved for improved [d]{.smallcaps}-xylose fermentation (Sato *et al.*[@bib56]). However, no consistent effect on anaerobic growth performance was observed when we integrated overexpression cassettes for *NQM1* and *TKL2* outside rather than inside the synthetic cluster of pentose-metabolism genes that was central to the strain design used by Verhoeven *et al.* ([@bib69]) and in the present study. We therefore cannot exclude that the negative impact of these expression cassettes on strains IMU078 and IMX696 was related to their physical location, e.g. by transcriptional interference with other neighbouring genes in a tightly packed cluster of highly expressed genes (Kuijpers *et al.*[@bib24]). Transcriptome analysis would provide a logical first step in attempts to elucidate the mechanism by which integration of the *NQM1* and/or *TKL2* cassettes prevents anaerobic growth on xylose in strains IMU078 and IMX696. However, the requirement for controlled bioreactor batch cultivation of multiple strains, some of which exhibit long lag phases, will make this a major experimental effort. Until this issue has been resolved, the work of Sato *et al.* ([@bib56]) and the present study indicate that it is prudent to omit *NQM1* and *TKL2* overexpression from initial designs for [d]{.smallcaps}-xylose-fermenting strains (Sato *et al.*[@bib56]).

Even within the CEN.PK genetic background, literature reports differ on the ability of XI-based engineered strains to grow anaerobically on [d]{.smallcaps}-xylose without additional laboratory evolution (Kuyper *et al.*[@bib28]; Karhumaa *et al.*[@bib21]; Brat, Boles and Wiedemann [@bib4]; Parachin *et al.*[@bib47]; Shen *et al.*[@bib57]; Hector *et al.*[@bib16]; Verhoeven *et al.*[@bib69]; Table [1](#tbl1){ref-type="table"}). In this study, increasing the initial concentration of biomass or CO~2~ in N~2~-sparged, anaerobic bioreactor cultures eliminated the extended anaerobic adaptation phase of *NQM1*/*TKL2* overexpressing strains. This observation showed that the inability of these strains to grow anaerobically on [d]{.smallcaps}-xylose, without first acquiring additional mutations, was conditional rather than absolute.

CO~2~ and bicarbonate are essential for carboxylation reactions in biosynthesis. In several bacteria, including *Escherichiacoli*, anaerobic growth without a long lag phase requires external supply of CO~2~ (Valley and Rettger [@bib64]; Repaske, Repaske and Mayer [@bib50]; Repaske and Clayton [@bib49]). The critical role of biosynthetic carboxylation reactions in *S. cerevisiae* is illustrated by the essentiality of carbonic anhydrase (Nce103), which interconverts CO~2~ and HCO~3~^−^, for growth on glucose in aerated cultures at ambient atmospheric pressure (Aguilera *et al.*[@bib1]). Despite the key roles of inorganic carbon in microbial metabolism, sparging with CO~2~-free N~2~ is commonly applied in anaerobic laboratory bioreactor cultivation of *S. cerevisiae*, as sparging with CO~2~ complicates quantification of its production in yeast metabolism. In glucose-grown cultures of wild-type *S. cerevisiae* strains, endogenous CO~2~ production by vigorous alcoholic fermentation likely provides sufficiently high 'sparking' levels of CO~2~ to enable growth initiation even at low initial biomass concentrations. Conversely, under the same conditions, the lower fermentation rates in engineered, non-evolved xylose-fermenting strains might not be able to provide the required CO~2~ levels. The striking impact of endogenous CO~2~ generation on anaerobic performance of engineered pentose-fermenting strains indicates that, especially for strains with low endogenous CO~2~ production rates, supplementing anaerobic, nitrogen-sparged bioreactor batch cultures with CO~2~ is a complicating but necessary measure. While relevant in laboratory settings, it should be borne in mind that industrial scale bioreactors are not sparged and have increased hydrostatic pressure, which in turn increases the CO~2~ partial pressure. Additionally, CO~2~ limitation is unlikely to occur during anaerobic fermentation of lignocellulosic hydrolysates, in which pentose fermentation is typically preceded by a vigorous glucose fermentation phase (Jansen *et al.*[@bib19]).

A recent ^13^C-flux analysis study showed that anaerobic fermentation of [d]{.smallcaps}-xylose, but not of glucose, by *E. coli* required lipid turn-over by β-oxidation to provide CO~2~ for anaplerotic (pyruvate or PEP to oxaloacetate) carboxylation reactions (Gonzalez, Long and Antoniewicz [@bib13]). Use of [l]{.smallcaps}-aspartate, whose transamination yields oxaloacetate, as the nitrogen source, completely eliminated the long anaerobic adaptation phase of *NQM1/TKL2*-expressing strains in N~2~-sparged, low-inoculum density cultures. This strong effect of bypassing a single carboxylation reaction might reflect a CO~2~ sparging effect that simply reduces the overall CO~2~ requirement for growth. Alternatively, the link between anaplerotic synthesis of oxaloacetate and [d]{.smallcaps}-xylose metabolism may be more specific. At physiological pH values, Mn^2+^, the preferred metal cofactor of *Piromyces* XylA (Lee *et al.*[@bib29]), is also a much better metal cofactor for yeast pyruvate carboxylase (Pyc1 and Pyc2) than Mg^2+^ (Cazzulo and Stoppani [@bib5]). High-level expression of *Piromyces xylA* might therefore result in a competition between the two enzymes for Mn^2+^. Alternatively, lower intracellular concentrations of acetyl-CoA, a key activator of pyruvate carboxylase, in xylose-grown cultures than in glucose-grown cultures might compromise *in vivo* activity of Pyc1 and Pyc2 (Bergdahl *et al.*[@bib3]).

In comparison with other strain backgrounds, the CEN.PK lineage may have at least one specific advantage for enabling anaerobic growth on [d]{.smallcaps}-xylose. Using a different *S. cerevisiae* genetic background, Sato *et al.* ([@bib56]) evolved a *Clostridium phytofermentans xylA*-expressing strain for anaerobic xylose fermentation and analysed causal mutations (Sato *et al.*[@bib56]). In addition to mutations that affected *GRE3*, whose deletion was already in the strain design of Kuyper *et al.* ([@bib27]), these included mutations in *IRA2* (Sato *et al.*[@bib56]). Loss of Ira2, an inhibitor of cAMP-PKA signalling, results in increased protein kinase A (PKA) activity (Tanaka *et al.*[@bib61]). The PKA/cAMP pathway is activated by glucose and regulates multiple cellular processes (Rolland, Winderickx and Thevelein [@bib51]; Santangelo [@bib55]). In contrast to glucose, xylose does not fully activate the cAMP/PKA pathway (Osiro *et al.*[@bib43]). In comparison with other *S. cerevisiae* genetic backgrounds, CEN.PK strains carry many sequence differences in genes involved in this signal-transduction pathway (Vanhalewyn *et al.*[@bib67]; Nijkamp *et al.*[@bib41]). Moreover, they exhibit a higher basal PKA activity than other laboratory *S. cerevisiae* strains (Kümmel *et al.*[@bib25]). The PKA/cAMP pathway regulates the glucose-dependent expression of the genes encoding several xylose-transporting members of the *S. cerevisiae* HXT (hexose transporter) family (i.e. *HXT1, HXT2*, *HXT4, HXT5* and *HXT7* (Hamacher *et al.*[@bib15]; Lee *et al.*[@bib32]; Kim and Johnston [@bib22]; Saloheimo *et al.*[@bib54])). A higher basal PKA activity might result in Hxt transporter landscapes that are conducive for fast xylose uptake and, thereby, enable the high rates of xylose fermentation that are required to sustain anaerobic growth.

We hope that this study will help colleagues with the design of pentose-fermenting strains and the experimental design of anaerobic yeast cultivation experiments, as well as that it will inspire further studies on the molecular basis for fast pentose fermentation in *S. cerevisiae*.
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